ROYALTY PHARMA Trademark

Trademark Overview


On Monday, September 14, 2020, a trademark application was filed for ROYALTY PHARMA with the United States Patent and Trademark Office. The USPTO has given the ROYALTY PHARMA trademark a serial number of 90178440. The federal status of this trademark filing is REGISTERED as of Tuesday, November 16, 2021. This trademark is owned by RP Management, LLC. The ROYALTY PHARMA trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Acquisition and merger consultation, namely, identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment

Financial services, namely, capital and fund investment services; investment management and investment advisory services; identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment, namely, financial analysis in the nature of financial modelling of the future value of biopharmaceutical royalties and complex structured financing
royalty pharma

General Information


Serial Number90178440
Word MarkROYALTY PHARMA
Filing DateMonday, September 14, 2020
Status700 - REGISTERED
Status DateTuesday, November 16, 2021
Registration Number6558516
Registration DateTuesday, November 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements


Disclaimer with Predetermined Text"ROYALTY"
Goods and ServicesAcquisition and merger consultation, namely, identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment
Goods and ServicesFinancial services, namely, capital and fund investment services; investment management and investment advisory services; identifying and acquiring revenue streams and monetization opportunities from the sale of biopharmaceutical products, pharmaceuticals, and medical diagnostics, devices, and equipment, namely, financial analysis in the nature of financial modelling of the future value of biopharmaceutical royalties and complex structured financing

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code035
First Use Anywhere DateTuesday, December 31, 1996
First Use In Commerce DateTuesday, December 31, 1996

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 21, 2020
Primary Code036
First Use Anywhere DateTuesday, December 31, 1996
First Use In Commerce DateTuesday, December 31, 1996

Trademark Owner History


Party NameRP Management, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Party NameRP Management, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Party NameRP Management, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Tuesday, November 16, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 14, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, July 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 14, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, July 14, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, May 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 12, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, February 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 4, 2021NON-FINAL ACTION E-MAILED
Thursday, February 4, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 26, 2021ASSIGNED TO EXAMINER
Wednesday, October 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 17, 2020NEW APPLICATION ENTERED IN TRAM